Profound Medical Corp (PROF) posted strong Q3 2026 revenue growth and margin expansion while extending its cash runway, even as it navigates rising operating costs and a leadership transition.
Profound Medical expands U.S. TULSA-PRO sales via Cook Medical, boosting installed base and recurring revenue potential.
Profound Medical (TSX:PRN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Profound Medical (PROF) surged 21% on a Q3 revenue beat, but 2026 sales lag and competition persist. Read here for a detailed analysis.
Gainers Profound Medical (NASDAQ:PROF) shares moved upwards by 21.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $207.5 million. Haemonetics (NYSE:HAE) stock moved upwards
A look at some small-cap stocks making news - or about to.
Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.
Profound Medical (PRN.TO) appointed Richard Fabian as its new president, effective immediately, the
Profound Medical (PROF) said Tuesday it appointed Richard Fabian as president, effective immediately
This is the newest page. Registered accounts read further back.